Page last updated: 2024-12-07

a 63162

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121876
CHEMBL ID418304
SCHEMBL ID7713248
MeSH IDM0187691

Synonyms (19)

Synonym
a 63162
acetamide, n-hydroxy-n-(1-(4-(phenylmethoxy)phenyl)ethyl)-
a-63162
n-hydroxy-n-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide
CHEMBL418304 ,
bdbm50022683
n-[1-(4-benzyloxy-phenyl)-ethyl]-n-isopropenyl-hydroxylamine
n-[1-(4-benzyloxy-phenyl)-ethyl]-n-hydroxy-acetamide
n-hydroxy-n-[1-(4-phenylmethoxyphenyl)ethyl]acetamide
111525-11-2
unii-0452y37yta
0452y37yta ,
acetamide,n-hydroxy-n-[1-[4-(phenylmethoxy)phenyl]ethyl]-
SCHEMBL7713248
n-hydroxy-n-(1-(4-(phenylmethoxy)phenyl)ethyl)acetamide
n-{1-[4-(benzyloxy)phenyl]ethyl}-n-hydroxyacetamide
DTXSID00912199
Q27247624
AKOS040747659
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)IC50 (µMol)0.34750.00462.018210.0000AID6821; AID6822; AID6823
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID6821In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay1994Journal of medicinal chemistry, Oct-14, Volume: 37, Issue:21
Synthesis and 5-lipoxygenase inhibitory activities of some novel 2-substituted 5-benzofuran hydroxamic acids.
AID187366Plasma concentration after 6 hr of peroral administration at 100 mg/kg was determined in rats1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID99733In vivo inhibition of biosynthesis of leukotriene in rat peritoneal anaphylaxis model1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID187365Plasma concentration after 3h of peroral administration at 100 mg/kg was determined in rats1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID6822In vitro inhibition of 5-lipoxygenase from RBL-1 cells1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID99606In vivo Inhibition of biosynthesis of leukotriene in rat peritoneal anaphylaxis model1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID187364Plasma concentration after 1 hr of peroral administration at 100 mg/kg was determined in rats1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID174487Plasma concentration 1 hr after oral administration of a dose of 200 uM/kg1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID6823In vitro inhibition of 5-lipoxygenase in RBL-1 cells1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
AID177682Effective dosage to inhibit leukotriene biosynthesis in rat peritoneal anaphylaxis model1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.67)18.7374
1990's23 (76.67)18.2507
2000's5 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.99 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.45%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (93.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]